Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EURE | ISIN: CA71716W2040 | Ticker-Symbol: G11
Frankfurt
03.10.25 | 08:06
0,001 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PHARMADRUG INC Chart 1 Jahr
5-Tage-Chart
PHARMADRUG INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0020,01413:03

Aktuelle News zur PHARMADRUG Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.07.Pharmadrug Inc (2): Pharmadrug enters LOI to acquire 40% of Canurta3
30.07.Pharmadrug Inc (2): Pharmadrug corrects July 30 NR1
30.07.Pharmadrug Inc (2): Pharmadrug resumes at 9:30 a.m. PT1
30.07.PharmaDrug Inc.: PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.549Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
PHARMADRUG Aktie jetzt für 0€ handeln
30.07.Pharmadrug Inc (2): Pharmadrug halted at 6:33 a.m. PT2
17.06.Pharmadrug Inc (2): Pharmadrug director, CEO Steen resigns3
16.06.PharmaDrug CEO Rob Steen steps down3
16.06.PharmaDrug Inc.: PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors389Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
06.06.Pharmadrug Inc (2): Pharmadrug puts itself on the block3
06.06.PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value306Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
15.11.24PharmaDrug Inc.: PharmaDrug Announces Issuance of Debenture Units881Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
31.10.24PharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units537Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
31.10.24PharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases431Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1